section name header

Pronunciation

myoo-PEER-oh-sin

Classifications

Therapeutic Classification: anti-infectives

Indications

REMS


Action

  • Inhibits bacterial protein synthesis.
Therapeutic effects:
  • Inhibition of bacterial growth and reproduction.

Spectrum:

Pharmacokinetics

Absorption: Minimal systemic absorption.

Distribution: Remains in the stratum corneum after topical use for prolonged periods of time (72 hr).

Metabolism/Excretion: Metabolized in the skin, removed by desquamation.

Half-Life: 17–36 min.

Time/Action Profile

(anti-infective effect)

ROUTEONSETPEAKDURATION
Topicalunknown3–5 days72 hr



Resolution of lesions.



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: burning, itching, pain, stinging

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Bactroban